Wall Street Zen Downgrades Vicarious Surgical (NYSE:RBOT) to Sell

Vicarious Surgical (NYSE:RBOT) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

Other equities research analysts also recently issued research reports about the company. BTIG Research reiterated a “neutral” rating on shares of Vicarious Surgical in a report on Friday, December 12th. Weiss Ratings restated a “sell (e+)” rating on shares of Vicarious Surgical in a research report on Wednesday, January 21st. Two analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Reduce” and an average target price of $7.00.

Vicarious Surgical Price Performance

Shares of NYSE RBOT opened at $2.21 on Friday. Vicarious Surgical has a fifty-two week low of $1.80 and a fifty-two week high of $16.35. The firm has a market capitalization of $14.48 million, a P/E ratio of -0.24 and a beta of 1.52. The company’s 50 day simple moving average is $2.50 and its 200 day simple moving average is $5.18.

Vicarious Surgical (NYSE:RBOT) last issued its earnings results on Wednesday, November 12th. The company reported ($1.91) EPS for the quarter, beating the consensus estimate of ($2.37) by $0.46. Sell-side analysts expect that Vicarious Surgical will post -10.89 EPS for the current fiscal year.

Institutional Investors Weigh In On Vicarious Surgical

Hedge funds have recently modified their holdings of the business. DNB Asset Management AS lifted its holdings in shares of Vicarious Surgical by 12.1% during the 2nd quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after purchasing an additional 3,154 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Vicarious Surgical by 22.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock worth $110,000 after purchasing an additional 3,615 shares in the last quarter. Finally, Connective Capital Management LLC acquired a new stake in Vicarious Surgical during the 3rd quarter worth approximately $169,000. Institutional investors and hedge funds own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.